Vertaling van "2-Hydroxy-3- " (Engels → Frans) :

TERMINOLOGIE

1, Hydroxy cholecalciferol
alphacalcidol

Propanoic acid, 2-hydroxy homopolymer
acide polylactique

decominol | decyloxy-3-hydroxy-2amino-1 propane hydrochlorate
chlorhydrate de décyloxy-3 hydroxy-2 amino-1 propane | decominol

hydroxy-quinoline | quinolinol
hydroxy-quinoléine

alpha-hydroxy acid | AHA [Abbr.]
alpha-hydroxyacide

pyridoxine [ PN | 3-hydroxy-4,5-dimethylol-alpha-picoline | 5-hydroxy-6-methyl-3,4-pyridinedimethanol | 2-methyl-3-hydroxy-4,5-dihydroxymethylpridine | 2-methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine | 2-methyl-3-hydroxy-4,5-bis-(hydroxymethyl)pyridine | 2-methyl-3-hydroxy-4,5-di- ]
pyridoxine [ PN | 3-hydroxy-4,5-diméthylol-alpha-picoline | 5-hydroxy-6-méthyl-3,4-pyridinediméthanol | 2-méthyl-3-hydroxy-4,5-dihydroxyméthylpyridine | 2-méthyl-4,5-bis(hydroxyméthyl)-3-hydroxypyridine | 2-méthyl-3-hydroxy-4,5-bis-(hydroxyméthyl)pyridine | 2-méthyl-3-hydroxy-4,5-di ]

3-hydroxy-2-methyl-4H-pyran-4-one [ maltol | 3-hydroxy-2-methyl-4-pyrone | 2-methyl-3-hydroxy-4-pyrone | 2-methyl pyromeconic acid | Palatol | larixinic acid | larixic acid | 3-hydroxy-2-methyl-gamma-pyrone | 2-methyl-3-oxy-gamma-pyrone ]
3-hydroxy-2-méthyl-4H-pyran-4-one [ maltol | Palatol | acide laricinique | acide larixinique | hydroxy-3 méthyl-2 pyrone-4 | hydroxy-3 méthyl-2 gamma pyrone ]

1-(4-hydroxy-3-methoxyphenyl)ethane-1,2-diol [ 3-methoxy-4-hydroxyphenylglycol | 1-(4-hydroxy-3-methoxyphenyl)-1,2-ethanediol | (4-hydroxy-3-methoxyphenyl) ethylene glycol | vanylglycol | methoxy-hydroxy-phenyl glycol ]
1-(4-hydroxy-3-méthoxyphényl)éthane-1,2-diol [ (méthoxy-3 hydroxy-4 phényl) éthylène-glycol ]

xanthinol | 7- [2-Hydroxy-3- (2-hydroxyethyl-N -methylamino) propyl] theophylline
xanthinol | hydroxy-2 [(hydroxy-2 éthyl) méthylamino] -3 propyl -7 théophylline

2-diethylaminoethyl-3-hydroxy-4-phenylbenzoate
(diéthylamino-2 éthyl)phényl-4 hydroxy-3 benzoate

IN-CONTEXT TRANSLATIONS

Advantame (ANS9801) is produced by chemical synthesis in a three-step process; production of the principal manufacturing intermediate, 3-hydroxy-4-methoxycinnamaldehyde (HMCA), followed by hydrogenation to form 3-(3-hydroxy-4-methoxyphenyl) propionaldehyde (HMPA). In the final step, the HMPA methanol solution (filtrate) is combined with aspartame to give the imine that under selective hydrogenation forms advantame.
L'advantame (ANS9801) est obtenu par un processus de synthèse chimique en trois étapes: production de l'intermédiaire principal de fabrication, le 3-hydroxy- 4-méthoxycinnamaldéhyde (HMCA), suivie d'une hydrogénation pour former du 3-(3-hydroxy-4-méthoxyphényl) propionaldéhyde (HMPA); dans l'étape finale, la solution de méthanol HMPA (filtrat) est combinée à de l'aspartame pour produire l'imine qui, à la suite d'une hydrogénation sélective, forme l'advantame.

flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
Flocoumafène (ISO); masse de réaction de cis-4-hydroxy-3-(1,2,3,4-tétrahydro-3-(4-(4-trifluorométhylbenzyloxy)phényl)-1-naphtyl)coumarine et de trans-4-hydroxy-3-(1,2,3,4-tétrahydro-3-(4-(4-trifluorométhylbenzyloxy)phényl)-1-naphtyl)coumarine

hydroxyisohexyl 3-cyclohexene carboxaldehyde (INCI); reaction mass of 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde and 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; [1]
hydroxyisohéxyl 3-cyclohexène carboxaldéhyde (INCI); masse de réaction de 4-(4-hydroxy-4-méthylpentyl)cyclohex-3-ène-1-carbaldéhyde et de 3-(4-hydroxy-4-méthylpentyl)cyclohex-3-ène-1-carbaldéhyde; [1]

flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
flocoumafen (ISO); masse de réaction de cis-4-hydroxy-3-(1,2,3,4-tétrahydro-3-(4-(4-trifluorométhylbenzyloxy)phényl)-1-naphtyl)coumarine et de trans-4-hydroxy-3-(1,2,3,4-tétrahydro-3-(4-(4-trifluorométhylbenzyloxy)phényl)-1-naphtyl)coumarine

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate and 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, silver(1+) salt, monohydrate
Acide 2-hydroxy-1,2,3-propanetricarboxylique, monohydrate et acide 2-hydroxy-1,2,3-propanetricarboxylique, sel d'argent (1+), monohydrate

A mixture of: N-[3-hydroxy-2-(2-methylacryloylamino-methoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-Bis-(2-methylacryloylamino-methoxy)propoxymethyl]-2-methylacrylamide; Methacrylamide; 2-Methyl-N-(2-methyl-acryloylaminomethoxymethyl)-acrylamide; N-(2,3-Dihydroxypropoxymethyl)-2-methylacrylamide
Mélange de: N -[3-hydroxy-2-(2-méthylacryloylamino-méthoxy)propoxyméthyle]-2-méthylacrylamide; N -[2,3-Bis-(2-méthylacryloylamino-méthoxy)propoxyméthyle]-2-méthylacrylamide; Méthacrylamide; 2-Méthyl-N -(2-méthyl-acryloylaminométhoxyméthyle)-acrylamide; N -(2,3-Dihydroxypropoxyméthyle)-2-méthylacrylamide

ethyldiamine-di (O-hydroxy P-methyl phenyl) acetic acid:
acide éthyldiamine-di (O-hydroxy-p-méthyl phényl) acétique:

hydroxy-2ethyl ethylene diamine triacetic acid:
acide hydroxy-2éthyl éthylène diamine triacétique: